title: Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
abstract: Factor V Leiden (FVLeiden) and prothrombin G20210A are the most common genetic causes of thrombophilia and established risk factors for different clinical manifestations of venous thromboembolism (VTE). This study investigated whether the clinical manifestation of VTE, the extension of deep vein thrombosis (DVT) and the presence of transient risk factors at the time of the first VTE, differed among patients with mutations (97 with FVLeiden; 33 with prothrombin G20210A) and in 109 patients without thrombophilia. Isolated pulmonary embolism (PE) was less prevalent in patients with FVLeiden (6%) and no thrombophilia (6%) than in those with prothrombin G20210A (15%). No difference was found in the incidence of distal DVT. Regarding the extension of proximal DVT, the lowest incidence for isolated popliteal vein and the highest for iliofemoral vein were observed in patients with prothrombin G20210A. No difference was observed between groups of patients with or without thrombophilia by unprovoked VTE. The pregnancy/puerperium was the most prevalent risk factor in carriers of prothrombin G20210A. Among FVLeiden carriers, the most prevalent risk factor was surgery, and in patients without thrombophilia, it was trauma (P < .05). Thrombosis of the upper limb was more frequent in a group without thrombophilia than in patients with mutations (P < .01). Transverse sinus venous thrombosis was present only in patients with prothrombin G20210A. Carriers of prothrombin G20210A have an increased risk of developing isolated PE and more severe clinical manifestations than those with FVLeiden or without thrombophilia.
authors.affiliation: Blood Transfusion Institute of Serbia, Belgrade, Serbia.
authors.forename: Mirjana
authors.initials: M
authors.lastname: Kovac
authors.forename: Gorana
authors.initials: G
authors.lastname: Mitic
authors.forename: Zeljko
authors.initials: Z
authors.lastname: Mikovic
authors.forename: Nebojsa
authors.initials: N
authors.lastname: Antonijevic
authors.forename: Valentina
authors.initials: V
authors.lastname: Djordjevic
authors.forename: Danijela
authors.initials: D
authors.lastname: Mikovic
authors.forename: Vesna
authors.initials: V
authors.lastname: Mandic
authors.forename: Ljiljana
authors.initials: L
authors.lastname: Rakicevic
authors.forename: Dragica
authors.initials: D
authors.lastname: Radojkovic
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005165:Factor V / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D017354:Point Mutation; D015995:Prevalence; D011516:Prothrombin / Q000235:genetics*; D011655:Pulmonary Embolism / Q000097:blood / Q000453:epidemiology / Q000235:genetics; D012307:Risk Factors; D019851:Thrombophilia / Q000097:blood / Q000453:epidemiology / Q000235:genetics; D054556:Venous Thromboembolism / Q000097:blood* / Q000453:epidemiology / Q000235:genetics*; D055815:Young Adult
chemical_list: C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin